Celltrion Holdings to cease selling shares internationally

Home > Business > Industry

print dictionary print

Celltrion Holdings to cease selling shares internationally

Celltrion, a Korean biopharmaceutical company listed on the Kosdaq market, yesterday announced that its largest shareholder Celltrion Holdings will stop selling its shares to transnational pharmaceutical companies.

The company pushed for an M&A in an effort to boost competitiveness in the global market, but the decision will become a shift in its marketing strategy, choosing to strengthen its sales network overseas.

The company’s foreign investors made the decision because they concluded that the M&A may raise financial uncertainties at a time when its stronghold biosimilar product Remsima is selling well in Europe.

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now